Moreover, in agreement with our analysis in liver cancer, Xia et al. [34] have previously established that reduced IQGAP2 levels lead to poor overall survival of HCC patients and it correlated with larger tumor size, advanced TNM stage and tumor differentiation. The gene discussed is IQGAP2; the disease is hepatocellular carcinoma.